Xiaowen Yu

6PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Neurology and neuromuscular diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2024
GDH1 exacerbates renal fibrosis by inhibiting the transcriptional activity of peroxisome proliferator-activated receptor gamma.

Jun Qin, Yingying Zhao, Shumin Li

|May 28, 2024
Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis.

Shumin Li, Jun Qin, Yingying Zhao

|Apr 23, 2023
Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway.

Hui Yuan, Yingying Zhao, Shumin Li

|May 13, 2021
Response to comment on "Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI".

Xiaowen Yu, Yue Zhang, Zhanjun Jia

|May 15, 2020
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI.

Xiaowen Yu, Man Xu, Xia Meng

|Aug 10, 2019
Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.

Xiao-Wen Yu, Dandan Wei, Ying-Sheng Gao

Pageof 1

Frequent Collaborators

3 joint publications

Songming Huang

2 joint publications

Shumin Li

2 joint publications

Qianqi Liu

2 joint publications

Yingying Zhao